MTHFR and Fertility

What Is MTHFR and How Does It Affect Fertility?

The term MTHFR refers to the gene that produces methylenetetrahydrofolate reductase, an enzyme critical for processing folate (vitamin B9) and regulating homocysteine levels in the body. Certain genetic variants or "mutations" in the MTHFR gene, most commonly C677T and A1298C, can alter enzyme function. This has led to significant interest in the potential role of MTHFR mutations in fertility, pregnancy outcomes, IVF success, and miscarriage risk. However, the research connecting MTHFR mutations and fertility is complex, controversial, and often misunderstood.

Some people trying to conceive—and some clinicians—seek MTHFR testing for fertility purposes, or consider supplements such as methylated folate due to these genetic variations. It is important to separate evidence-based information from myths and to understand what the current data say about MTHFR, reproductive health, and treatment options.

Key Takeaways

MTHFR is an enzyme involved in folate metabolism and homocysteine regulation, which are important for cell division, DNA synthesis, and overall reproductive health.
MTHFR mutations—especially C677T and A1298C—are common genetic variations that may reduce enzyme activity.
The relationship between MTHFR mutations and fertility or miscarriage is debated, with research offering mixed results.
Testing for MTHFR mutations is not universally recommended in fertility assessments unless there are specific clinical reasons.
Some people with MTHFR variants may have elevated homocysteine, which could affect blood clotting and pregnancy outcomes.
Use of methylated folate is a common strategy for those with MTHFR variants, but the benefits are not universally proven.
The MTHFR controversy involves conflicting guidelines, with some experts arguing testing and treatment are unnecessary for most people.
IVF outcomes appear generally unaffected by MTHFR status for most, based on the current evidence.
Modifiable lifestyle and nutrition factors can often have a much greater impact on fertility than MTHFR status alone.
Always discuss personalized fertility treatment with your reproductive endocrinologist or genetic counselor.

What Is MTHFR?
How Does MTHFR Work in the Body and Reproductive System?
What Are the Common MTHFR Mutations (C677T and A1298C) and What Do They Mean?
How Are MTHFR and Fertility Connected?
Does MTHFR Increase the Risk of Miscarriage?
How Is MTHFR Tested in a Fertility Setting?
MTHFR Reference Ranges, Homocysteine, and Fertility Implications
Treatment Options for MTHFR Mutations in Fertility
MTHFR and IVF: Is There an Impact?
Risk Factors, Controversies, and Current Guidelines
Frequently Asked Questions About MTHFR and Fertility
References and Further Reading
Disclaimer

What Is MTHFR?

MTHFR (methylenetetrahydrofolate reductase) is a key enzyme required for the metabolism of folate—a B vitamin essential for DNA synthesis, cell division, and methylation reactions in the body. MTHFR enables the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, which is necessary for converting homocysteine to methionine, another essential amino acid source.

Variants or mutations in the MTHFR gene, most commonly C677T and A1298C, can reduce enzyme function. This may lead to increased homocysteine levels (hyperhomocysteinemia) and disruptions in folate metabolism. These changes have been implicated—though not conclusively—in various reproductive and pregnancy challenges.

Quick Facts Table: MTHFR and Fertility

Feature	Description
Full Name	Methylenetetrahydrofolate reductase
Gene Symbol	MTHFR
Key Enzyme Function	Enables folate metabolism, regulates homocysteine
Common Variants	C677T, A1298C
Inheritance	Autosomal (from either parent)
Potential Reproductive Impacts	Possibly linked to miscarriage, neural tube defects, rarely infertility
Testing	Blood test for genetics, homocysteine, and folate metabolites
Treatment	Methylated folate, B vitamins, rarely anticoagulants
Controversy	Routine testing rarely recommended in fertility or pregnancy by most guidelines

How Does MTHFR Work in the Body and Reproductive System?

MTHFR Enzyme Pathway

MTHFR catalyzes a critical step in the conversion of dietary and supplemental folic acid and naturally occurring folate into a usable form for methylation. The methylation cycle is essential for:

DNA synthesis and repair
Regulation of gene expression through epigenetics
Detoxification processes
Proper closure of the neural tube in fetal development
Healthy egg and sperm development

When the MTHFR enzyme’s function is reduced (due to genetics or other factors), homocysteine levels may rise, and efficient methylation is impaired. Elevated homocysteine is considered a risk factor for cardiovascular disease and, potentially, some reproductive complications source.

Clinical Terms and Tissue Relevance

Oocyte (egg) development and DNA health are supported by optimal folate metabolism.
Sperm production and quality may also be indirectly influenced by homocysteine and folate metabolism.
Endometrial receptivity and placental health are believed to be affected by methylation capacity during implantation and fetal growth.

Key Point: While the MTHFR enzyme is essential, most people with a MTHFR variant have sufficient enzymatic activity, especially if they maintain good nutritional status with respect to folate, B12, and B6.

What Are the Common MTHFR Mutations (C677T and A1298C) and What Do They Mean?

Overview of Genetic Variants

C677T: The most-studied MTHFR variant, in which cytosine (C) is replaced by thymine (T) at position 677. Having one (heterozygous) or two (homozygous) copies affects enzyme function with different severity.
A1298C: A less well-studied variant where adenine (A) is swapped for cytosine (C) at position 1298. Its impact on enzyme activity is generally less severe than C677T but may play a role if combined with other variants.

Genotypes and Their Effects

Genotype	Prevalence (Varies by ethnicity)	Estimated Enzyme Activity	Potential Health Impact
Normal	~40% (most populations)	100%	Typical folate metabolism
C677T Heterozygous	~40%	~65%	Mildly reduced, often clinically insignificant
C677T Homozygous	~10–15%	~30–40%	Higher homocysteine risk, especially if low in folate
A1298C Heterozygous	~30–40%	Mild reduction	Usually not clinically significant alone
Compound Heterozygous (C677T + A1298C)	~2–5%	More substantial reduction	Potential additive effects, but clinical significance varies

Synonyms and Potential Confusions

"MTHFR mutation" refers to these gene variations, but "mutation" is a technical term—for most, these are polymorphisms (common in the population), not rare, severe mutations.
Having a variant does not guarantee health or fertility problems.

How Are MTHFR and Fertility Connected?

Key Areas of Research and Debate

MTHFR mutations and their effect on fertility remain controversial. The main areas of concern include:

Miscarriage: Some early studies suggested a possible association between certain MTHFR variants and recurrent pregnancy loss, but most meta-analyses and expert groups have found the link to be weak, inconsistent, or confounded by other factors source.
Implantation and IVF: There is little evidence that MTHFR mutations themselves impair embryo implantation or IVF success rates.
Folate-Dependent Pathways: Proper methylation and low homocysteine are needed for oocyte and sperm DNA integrity. Severe folate deficiencies or high homocysteine are more clearly problematic than having an MTHFR variant per se.
Placental and Vascular Health: There may be a modest risk of placental complications in individuals with poor methylation status and high homocysteine, but this is rare with appropriate nutrition.

Who May Be Affected?

Recurrent pregnancy loss—when other causes are excluded, discussion of homocysteine and MTHFR may arise.
Individuals with unexplained elevated homocysteine.
Certain ethnic groups with higher prevalence of specific variants.
Those with a history of neural tube defects or a personal/family history of blood clotting disorders.

Did you know? Around 30–50% of the global population carries at least one MTHFR variant, but most never experience fertility issues as a result.

Does MTHFR Increase the Risk of Miscarriage?

Historical Concerns

Studies in the 1990s and early 2000s raised concerns that MTHFR mutations, especially C677T in the homozygous form, might increase the risk of recurrent miscarriage or placental complications. Some research suggested hyperhomocysteinemia (elevated homocysteine) might impair uteroplacental blood flow, affecting implantation or fetal development source.

What Does the Current Evidence Say?

Meta-analyses and recent large studies now indicate that, for most people, carrying an MTHFR mutation alone does not raise miscarriage risk in the absence of other clotting factors or high homocysteine source.
The American College of Obstetricians and Gynecologists (ACOG) and American College of Medical Genetics (ACMG) do not recommend routine testing for MTHFR in cases of miscarriage source.

Modifying Factors

Factors that may compound risk include:

Elevated homocysteine levels
Low dietary folate
Coinheritance of other thrombophilia genes (Factor V Leiden, prothrombin mutation)
Certain lifestyle factors (smoking, poor diet, vitamin B deficiencies)

How Is MTHFR Tested in a Fertility Setting?

Genetic Testing

A blood or saliva test can identify MTHFR gene variants (most frequently testing C677T and A1298C).
These are usually only performed if there is a clinical indication (e.g., unexplained blood clots, recurrent miscarriage without clear cause, or a history suggesting hyperhomocysteinemia).
Testing may identify whether a person is heterozygous (one copy of a variant) or homozygous (two copies).

Homocysteine Testing

A separate blood test measures total plasma homocysteine.
High homocysteine may suggest a need to optimize folate, B12, and B6 status regardless of MTHFR genotype.

Folate Metabolites

Labs might measure total folate, serum B12, methylmalonic acid, and/or red blood cell folate to assess overall methylation nutrient reserves.

Key Point: Most reproductive endocrinologists do not use routine MTHFR genetic testing, unless there are compelling risk factors or unexplained recurrent pregnancy losses.

MTHFR Reference Ranges, Homocysteine, and Fertility Implications

What Is a Normal Homocysteine Level?

General reference range: 5–15 μmol/L, depending on the lab.
Optimal for pregnancy: Some guidelines suggest <10 μmol/L is preferable for people trying to conceive or who are pregnant source.
Levels above 15 μmol/L are considered elevated (hyperhomocysteinemia) and may justify nutrition or supplement intervention.

Homocysteine and Fertility: What’s the Connection?

Elevated homocysteine has been linked to increased risk of miscarriage, preeclampsia, placental abruption, and some birth defects—but most evidence links the risk to homocysteine itself, not just the presence of an MTHFR variant source.
Lowering homocysteine (by ensuring adequate intake of folate, B12, and B6) can reduce these risks.

Laboratory Values Table

Lab Marker	Reference Range	Implication for Fertility
Homocysteine	5–15 μmol/L	>10 μmol/L may prompt intervention in TTC
Red Blood Cell Folate	140–628 ng/mL (varies)	Low values require supplementation
Serum Vitamin B12	200–900 pg/mL	Ensure within normal range

Ranges vary by lab and population; discuss results with your physician.

Treatment Options for MTHFR Mutations in Fertility

Do All People With MTHFR Variants Need Treatment?

No. Most people with MTHFR variants never require specific treatment, especially if homocysteine and other labs are normal and there is no personal or family history of clotting or pregnancy complications.

Dietary and Supplementation Strategies

Methylated folate (5-MTHF): Some experts advocate the use of this bioactive form (over standard folic acid) for people with MTHFR variants, though robust clinical trial evidence is limited. Methylfolate bypasses the MTHFR enzyme step, ensuring the body gets the form it needs source.
B12 and B6: Adequate amounts are essential for proper methylation and homocysteine recycling.
Avoiding synthetic folic acid in high doses may be prudent for those with confirmed severe enzyme deficiency, but for most, standard prenatal vitamins suffice.
Nutrition: A diet rich in green vegetables, beans, lentils, citrus, and whole grains supports optimal methylation.

Medications

Rarely: For people with both MTHFR mutations and coexisting clotting disorders, a clinician might consider low-dose aspirin or anticoagulants; this is not standard unless other thrombophilias are present.

Lifestyle Modifications

Stop smoking, reduce alcohol, maintain a healthy BMI, and manage chronic conditions to support overall vascular and reproductive health.

Risk-Reduction Table: MTHFR in Fertility

Risk/Concern	Recommended Approach
Elevated homocysteine	Methylated folate, B12, B6, diet changes
Previous miscarriage	Optimized nutrient status, clinical eval
IVF or ART procedure	Follow standard protocols, supplement as needed
No symptoms or risk	Routine prenatal care, healthy lifestyle

MTHFR and IVF: Is There an Impact?

Evidence Review

IVF outcomes (fertilization, implantation, pregnancy rates): Available studies show no significant difference between those with and without MTHFR variants when controlled for other factors source.
Egg and sperm quality: As long as folate and B12 status are optimized, DNA and chromosomal health appear not to be affected by MTHFR genotype alone.
ART protocols: Clinicians typically recommend standard or methylated folate for all IVF patients, regardless of MTHFR status.

Did you know? Clinics rarely screen for MTHFR mutations during IVF cycles, as current evidence does not show improved outcomes with genotype-driven interventions.

Risk Factors, Controversies, and Current Guidelines

The MTHFR Controversy: Science vs. Hype

Some clinics, wellness sites, and supplement companies heavily market MTHFR testing and methylated folate as essential for fertility and pregnancy. However, most major organizations recommend against routine MTHFR gene testing in people with fertility concerns, due to:

Lack of strong evidence linking MTHFR status to infertility or poor IVF outcomes
High prevalence of these variants in the general population (many with no adverse effects)
The vast majority of neural tube defects and pregnancy losses are not due to MTHFR variants

Guideline Summary Table

Organization	Testing Recommendation
ACOG/ACMG	Do not recommend MTHFR genotyping for miscarriage or general fertility workup
ESHRE (EU)	Genotyping rarely indicated unless unexplained thrombosis
ASRM	Do not recommend routine testing or altering ART protocols

When Might Testing Be Considered?

Unexplained, recurrent blood clots
Severe, unexplained hyperhomocysteinemia
Family history of MTHFR-related health issues
Multiple unexplained pregnancy complications after ruling out other causes

Myths vs. Facts About MTHFR and Fertility

Myth	Fact
MTHFR mutation always causes miscarriage or infertility	Most people with variants have normal pregnancies
Everyone with MTHFR variants needs methylfolate	Only those with high homocysteine or deficiencies benefit
MTHFR should be tested before every IVF or pregnancy	Routine testing is not recommended by major health groups
Folic acid is always unsafe if you have MTHFR	Most people process folic acid fine, but methylfolate may help some

Frequently Asked Questions About MTHFR and Fertility

What does MTHFR mean in fertility?

MTHFR refers to the methylenetetrahydrofolate reductase gene and enzyme, which helps process folate and manage homocysteine levels. In fertility, MTHFR is relevant mainly due to claims that certain gene variants might affect miscarriage risk, DNA methylation, or embryo development. However, most people with these variants have no trouble conceiving or carrying a pregnancy source.

What is a normal MTHFR gene test result?

The standard MTHFR gene test reports whether you carry one or two copies of the C677T or A1298C variants (heterozygous or homozygous). "Normal" means no variant is detected; most carriers of one variant have near-normal enzyme function, and only a small percentage have two copies with reduced activity. But having a variant does not automatically signal a problem.

How is MTHFR tested or diagnosed in a fertility workup?

Testing is done with a blood or saliva DNA test, primarily looking for common variants (C677T and A1298C). This is not part of routine fertility evaluation unless you have a history suggesting clotting or recurrent pregnancy loss. Homocysteine can also be tested with a blood sample.

When during my cycle should MTHFR or homocysteine be tested?

MTHFR genetic testing can be done at any time, as your genes do not change. Homocysteine is usually tested after fasting for 8–12 hours, but timing within your menstrual cycle does not significantly affect results.

What does a positive MTHFR C677T or A1298C result mean?

A positive test means you carry a common gene variant that modestly reduces MTHFR enzyme efficiency. For most, it is not a problem, especially if dietary folate is adequate. Only rarely does it call for special intervention, and even then, usually only if other risk factors are present.

Can MTHFR change over time?

No. Your genetic code, including the MTHFR gene, is set at birth and remains the same throughout your life. What can change is your nutritional status, homocysteine levels, and risk profile.

How does age affect MTHFR’s impact on fertility?

Age does not change your MTHFR genotype. However, older age is associated with higher risks for egg quality decline and pregnancy loss, which are unrelated to MTHFR. Older individuals may also be at higher risk of nutritional deficiencies that could impact methylation.

Does MTHFR affect IVF success rates?

Current evidence indicates that, for most people, MTHFR status does not meaningfully affect IVF fertilization, implantation, or live birth rates. Maintaining optimal folate and B vitamin status is standard for all IVF patients.

Is MTHFR testing covered by insurance?

Coverage varies significantly. Most insurance plans do not cover MTHFR testing solely for fertility reasons, unless there is a personal or family history of clotting or related vascular events. Check with your provider for specifics.

Can lifestyle or nutrition improve fertility in people with MTHFR variants?

Yes. Ensuring adequate intake of natural folate-rich foods (leafy greens, legumes, fortified grains) and necessary B vitamins can help everyone, regardless of MTHFR status. Those with elevated homocysteine or deficiency may benefit from methylated folate.

Are there supplements that help with MTHFR and fertility?

Some people with MTHFR variants may benefit from taking methylated folate (5-methyltetrahydrofolate), which bypasses the enzyme deficiency, and sometimes vitamin B12 and B6. However, supplements are not universally required—always check labs and consult your clinician.

What is the difference between MTHFR mutation and other fertility factors?

MTHFR is a genetic variant mostly affecting folate metabolism. Other fertility factors include hormone levels (FSH, LH, AMH), tube patency, sperm quality, and uterine anatomy. These issues are typically more impactful on fertility than MTHFR status.

How long does it take to see improvement in homocysteine after starting methylated folate?

Homocysteine levels may decrease within 4–12 weeks of starting methylated folate and B-vitamin supplementation, though individual responses vary source. Repeat testing is often recommended after several months if levels were initially high.

Is MTHFR testing helpful after recurrent miscarriage?

For most, no. Since most large studies have not found MTHFR variants independently increase miscarriage risk, and because other causes are more common, testing is not routinely recommended. Prioritize evaluation for anatomical, hormonal, and other blood clotting factors.

Is it risky or harmful to take methylated folate if I don’t have an MTHFR variant?

Generally, methylated folate is safe for most people and may be used in place of standard folic acid, particularly in prenatal vitamins. However, there is no clear evidence that it provides extra benefits if you do not have high homocysteine or a documented deficiency.

When should I see a fertility specialist about MTHFR?

See a fertility specialist if you have:

Recurrent pregnancy loss with no other explanation
Personal or family history suggesting blood clots or thrombophilias
Persistently elevated homocysteine despite good nutrition
Multiple failed fertility treatments without clear cause

For routine fertility care, MTHFR status is usually not a primary concern.

What questions should I ask my doctor if I have an MTHFR variant?

Is my homocysteine elevated and does it need to be treated?
Do I need a different prenatal or B-vitamin supplement?
Are there other causes for my fertility or miscarriage challenges?
Should I have additional testing for clotting disorders?
How should my care plan be tailored given my personal and family history?

References and Further Reading

Bailey LB, Gregory JF. Folate metabolism and requirements. https://pubmed.ncbi.nlm.nih.gov/20091749/
Mutch DM, et al. Homocysteine, folate metabolism, and cardiovascular risk. https://pubmed.ncbi.nlm.nih.gov/21457902/
Wang Q, et al. MTHFR polymorphisms and recurrent miscarriage: A meta-analysis. https://pubmed.ncbi.nlm.nih.gov/24539172/
The American College of Medical Genetics (ACMG). MTHFR: Frequently asked questions. https://www.acmg.net/PDFLibrary/MTHFR-Statement-GIM-1533-4466-12-8-517.pdf
Nelen WL, et al. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis. https://pubmed.ncbi.nlm.nih.gov/16169345/
van der Molen EF, et al. Folate, homocysteine, and gene polymorphisms in relation to miscarriage. https://pubmed.ncbi.nlm.nih.gov/25128924/
Hogeveen M, et al. Homocysteine and pregnancy: clinical impact and management. https://pubmed.ncbi.nlm.nih.gov/25208928/
Marquez-Aguirre AL, et al. Folate metabolism and supplementation—the MTHFR polymorphism. https://pubmed.ncbi.nlm.nih.gov/18693079/
Sills ES, et al. MTHFR genotypes and IVF outcomes. https://pubmed.ncbi.nlm.nih.gov/30908919/
Reyes LM, et al. Homocysteine, nutrition, and reproductive outcomes. https://pubmed.ncbi.nlm.nih.gov/23523852/
Lathrop E, et al. Homocysteine-lowering interventions in reproductive-age people. https://pubmed.ncbi.nlm.nih.gov/20463631/
American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin: Early Pregnancy Loss. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/10/early-pregnancy-loss
European Society of Human Reproduction and Embryology (ESHRE): Thrombophilia in ART. https://www.eshre.eu/Guidelines-and-Legal/Guidelines

Disclaimer

This article is for informational and educational purposes only and does not constitute medical or mental health advice. It is not a substitute for speaking with a qualified healthcare provider, licensed therapist, or other professional who can consider your individual situation.